CD44 and cancer: Furthermore, in 2012, Saigusa and colleagues demonstrated that gene expression levels of LGR5 in cancer cells and of CD44 in stromal cells were significantly correlated with disease recurrence, whereas only elevated levels of stromal CD44 was an independent prognostic factor of recurrence and overall survival of RC patients after preoperative CRT [43].